The production of retatrutide, a novel dual activator targeting both GLP-1 and GIP receptors, represents a complex several-stage organic process. Initial routes focused on peptide section coupling, utilizing solid-phase production methodologies to build the long protein sequence. Subsequent investigation has explored alternative approaches, includi